Skip to main content
Log in

Localised proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography

  • Diagnostic Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

In 32 patients with gliomas, one- and two-dimensional proton magnetic resonance spectroscopy (1H-MRS) has been conducted, the latter allowing reconstruction of spectroscopic data into a spectroscopic image (MRSI), showing the distribution of the various metabolite concentrations over the cross-sectional plane. For lack of absolute concentrations, the measured concentrations of phosphocholine (CHOL),N-acetyl-L-aspartate (NAA), and lactate (LAC) were conventionally expressed in ratios relative to that of creatine (CREAT). Compared to normal brain tissue, an increased CHOL/CREAT ratio was found in all groups of tumours, in glioblastomas, high-, middle- and low-grade astrocytomas both at the margin and the core of the tumours, but in oligodendrogliomas only at the margin. This is consistent with an increased phosphocholine turnover in relation to membrane biosynthesis by the proliferating cells. The NAA/CREAT ratio was decreased in all groups of tumours, both in the centre and at the margin, reflecting replacement of functioning neurons by neoplastic cells. The LAC/ CREAT ratio was elevated in the core of malignant gliomas, which may be the result of a prevailing glycolysis, characteristic of tumours, possibly in conjunction with hypoxia/ischaemia. In the perifocal oedema, there was neither elevation of the CHOL/CREAT ratio nor decrease of the NAA/CREAT ratio; an increased LAC/CREAT ratio therefore rather reflected ischaemia/hypoxia probably due to locally elevated pressure and compromised regional perfusion. In the normal brain, the metabolite ratios of grey matter did not differ from those of white matter. The frontal lobe and basal ganglia showed lower NAA/CREAT ratios than the other cerebral areas. In 7 patients positron emission tomography was also performed with [18F]fluoro-2-deoxy-D-glucose (18FDG) or L-[1-11C]-tyrosine (11C-TYR); the latter demonstrated a pattern of11C-TYR uptake similar to that of CHOL elevation in the MRSI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Arnold DL, Matthews PM, Villemure JG (1989) Combined proton and phosphorus MRS of human brain tumours in vivo: preliminary observations on the effects of tissue heterogeneity on metabolite ratio and pH measurements (abstract). Proc Soc Magn Reson Med, 8th Annual Meeting, Berkeley, p 75

  2. Ross BD, Merkle H, Staewen RS, Garwood M (1989) Spatially localized1H spectroscopy of a rat intracerebral glioma (abstract). Proc Soc Magn Reson Med, 8th Annual Meeting, Berkeley, p 146

  3. Heerschap A, Luyten PR, Bernsen HJ, et al (1989) Combined1H and31P NMR spectroscopic examination of human intracranial tumours at 1.5 tesla (abstract). Proc Soc Magn Reson Med, 8th Annual Meeting, Berkeley, p 430

  4. Sauter R, Loeffler W, Bruhn H, Frahm J (1989) High resolution localized proton MR spectroscopy at 1.0 Tesla (abstract). Proc Soc Magn Reson Med, 8th Annual Meeting, Berkeley, p 443

  5. Felber S, Sauter R, Aichner F (1989) Localized 1H spectroscopy applied to cerebral neoplasms and ischaemia at a clinical 1.5 T MR-system (abstract). Proc Soc Magn Reson Med, 8th Annual Meeting, Berkeley, p 450

  6. Gadian DG, Porteous R, Gill SS, et al (1989) Metabolites as1H NMR markers of brain disease (abstract). Proc Soc Magn Reson Med, 8th Annual Meeting, Berkeley, p 487

  7. Bruhn H, Frahm J, Gyngell ML, et al (1989) Noninvasive differentiation of tumours with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumours. Radiology 172: 541–548

    Google Scholar 

  8. Ott D, Ernst T, Hennig J (1990) Clinical value of1H spectroscopy of brain tumours (abstract). Proc Soc Magn Reson Med, 9th Annual Meeting, Berkeley, p 105

  9. Remy C, Decorps M, Bourgeois D, Lefur Y, Devoulon P, Benabid AL (1989)1H spectroscopic imaging study of intracerebral tumour models in rat (abstract). Proc Soc Magn Reson Med, 9th Annual Meeting, Berkeley, p 136

  10. Arnold DL, Villemure JG (1990) Clinical evaluation of primary brain tumours using in vivo magnetic resonance spectroscopy (abstract). Proc Soc Magn Reson Med, 9th Annual Meeting, Berkeley, p 990

  11. Alger JR, Fulham JA, Frank JA, et al (1990) Metabolism of human glioma assessed by FGD-PET and1H-MRS in thirty patients (abstract). Proc Soc Magn Reson Med, 9th Annual Meeting, Berkeley, p 989

  12. Luyten PR, Mariën AJH, Heindel W, Gerwen PHJ van, Herholz K, Hollander JA den, Friedmann G, Heiss WD (1990) Metabolic imaging of patients with intracranial tumours: H-1 MR spectroscopic imaging and PET. Radiology 176: 791–799

    Google Scholar 

  13. Kugel H, Heindel W, Ernestus RL, Bunke J, Friedmann G (1990) Imageguided localized1H NMR spectroscopy: a non-invasive tool for differentiation of human brain tumours? (abstract). Proc Soc Magn Reson Med, 10th Annual Meeting, Berkeley, p 589

  14. Bizzi A, Fulham MJ, Sobering GS, et al (1991) Clinical evaluation of human gliomas with1H-MR spectroscopic imaging and [18F]-fluorodeoxyglucose PET (abstract). Proc Soc Magn Reson Med, 10th Annual Meeting, Berkeley, p 399

  15. Frank JA, Alger JR, Bizzi A, et al (1990) Evaluation of low and high grade gliomas by proton MRS, gadolinium-DTPA enhanced MRI and FDG-PET: a study in 40 patients (abstract). Proc Soc Magn Reson Med, 9th Annual Meeting, Berkeley, p 102

  16. Bottomley PA (1989) Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe? Radiology 170: 1–15

    Google Scholar 

  17. Warburg O (1956) On the origin of cancer cells. Science 123: 309–314

    Google Scholar 

  18. Daemen BJG, Elsinga PH, Paans AMJ, Wieringa AR, Konings AWT, Vaalburg W (1992) Radiation-induced inhibition of tumour growth as monitored by PET using L-[1-11-C]-tyrosine and11FDG. J Nucl Med 33: 373–379

    Google Scholar 

  19. Hamacher K, Coenen HH, Stöcklin G (1986) Efficient stereospecific synthesis of no-carrier-added 2-[18F]fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27: 235–238

    Google Scholar 

  20. Bolster JM, Vaalburg W, Paans AMJ, et al (1986) Carbon-11C labelled tyrosine to study tumour metabolism by positron emission tomography (PET). Eur J Nucl Med 12: 321–324

    Google Scholar 

  21. Tunggal B, Hofmann K, Stoffel W (1990) In vivo13C nuclear magnetic resonance investigation of choline metabolism in rabbit brain. Magn Reson Med 13: 90–102

    Google Scholar 

  22. Hida K, Nakada T, Kwee IL (1990) Proton and31P spectroscopy of developing brain (abstract). Proc Soc Magn Reson Med, 9th Annual Meeting, Berkeley, p 1054

  23. Hüppi PS, Posse S, Lazeyras F, et al (1991) Brain development in preterm and term babies studied with1H-magnetic resonance spectroscopy using short-echo time STEAM technique (abstract). Proc Soc Magn Reson Med, 10th Annual Meeting, Berkeley, p 377

  24. Christiansen P, Larsson HBW, Frederiksen J, Jensen M, Henriksen O (1990) Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis (abstract). Proc Soc Magn Reson Med, 9th Annual Meeting, Berkeley, p 109

  25. Rothman DL (1991) Brain spectroscopy of white matter diseases (abstract). Proc Soc Magn Reson Med, 10th Annual Meeting, Berkeley, p 78

  26. Brenner RE, Williams SCR, Munro PMG, Barker GJ, Hawkins CP, McDonald WI (1991) The evolution of the in-vivo proton NMR spectrum in acute EAE (abstract). Proc Soc Magn Reson Med, 10th Annual Meeting, Berkeley, p 430

  27. Larsson HBW, Christiansen P, Jensen M, et al (1991) Localized in vitro spectroscopy in the brain of patients with multiple sclerosis. Magn Res Med 22: 23–31

    Google Scholar 

  28. Bruhn H, Frahm J, Gyngell ML, Merboldt KD, Hänicke W, Sauter R (1989) Cerebral metabolism in man after acute stroke: new observations using localized proton NMR spectroscopy. Magn Reson Med 9: 126–131

    Google Scholar 

  29. Luyten PR, Rijen PC van, Tulleken CAF, Hollander JA den (1989) Metabolite mapping using1H NMR spectroscopic imaging in patients with cerebrovascular disease (abstract). Proc Soc Magn Reson Med, 8th Annual Meeting, Berkeley, p 452

  30. Ott D, Hennig J (1990) In vivo1H spectroscopy in cerebral ischemia (abstract). Proc Soc Magn Reson Med, 9th Annual Meeting, Berkeley, p 1011

  31. Duijn JH, Matson GB, Maudsley AA, Hugg JW, Weiner MW (1992) Human brain infarction: proton MR spectroscopy. Radiology 183: 711–718

    Google Scholar 

  32. Grodd W, Krägeloh-Mann I, Klose U, Sauter R (1990) Volume selective proton spectroscopy of the brain in children with neurodegenerative disorders (abstract). Proc Soc Magn Reson Med, 9th Annual Meeting, Berkeley, p 1050

  33. Connelly A, Austin SJ, Gadian DG (1991) Localised1H MRS in the paediatric brain: age and regional dependence (abstract). Proc Soc Magn Reson Med, 10th Annual Meeting, Berkeley, p 379

  34. Wang Z, Bogdan AR, Detre JA, Gusnard DA, Zimmerman RA (1991) In vivo1H MRS studies of pediatric metabolic disease (abstract). Proc Soc Magn Reson Med, 10th Annual Meeting, Berkeley, p 380

  35. Barker PB, Kumar AJ, Naidu S (1991)1H NMR spectroscopy of Canavan's disease (abstract). Proc Soc Magn Reson Med, 10th Annual Meeting, Berkeley, p 381

  36. Ishiwata K, Ido T, Nakajima T, Ohrui H, Kijima-Suda I, Itoh M (1990) Tumour uptake study of 18F-labeled N-acetylneuraminic acid. Int J Rad Appl Instrum [B] 17: 363–367

    Google Scholar 

  37. Ishiwata K, Tomura M, Ido T, Iwata R, Itoh J, Kameyama M (1989) In vivo assessment of 6-deoxy-6-[18F]fluoro-D-galactose as a PET tracer for studying galactose metabolism. Int J Rad Appl Instrum [B] 16: 775–781

    Google Scholar 

  38. Kugel H, Heindel W, Ernestus RI, Bunke J, Mesnil R du, Friedmann G (1992) Human brain tumours: spectral patterns detected with localized H-1 MR spectroscopy. Radiology 183: 701–709

    Google Scholar 

  39. Arnold DL, Shoubridge EA, Villemure JG, Feindel W (1990) Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo: preliminary observations on tumour grading. NMR Biomed 3: 184–189

    Google Scholar 

  40. Oberhaensli RD, Hilton-Jones D, Bore PJ, Hands LJ, Rampling BP, Radda GK (1986) Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy. Lancet II: 8–11

    Google Scholar 

  41. Heindel W, Bunke J, Steinbrich W (1987) Image-guided localized31P NMR spectroscopy of the human brain at 1.5 T. Fortschr Röntgenstr 147: 374–378

    Google Scholar 

  42. Nadler JV, Cooper JR (1972) Metabolism of the aspartyl moiety ofN-acetyl-L-aspartic acid in the rat brain. J Neurochem 19: 2091–2105

    Google Scholar 

  43. D'Adamo AF, Yatsu FM (1966) Acetate metabolism in the nervous system.N-acetyl-L-aspartic acid and the biosynthesis of brain lipids. J Neurochem 13: 961–965

    Google Scholar 

  44. Birken DL, Oldendorf WH (1989)N-acetyl-L-aspartic acid: literature review of a compound prominent in1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 13: 23–31

    Google Scholar 

  45. Go KG (1991) Cerebral pathophysiology. An integral approach with some emphasis on clinical implications. Elsevier, Amsterdam, pp 321–328

    Google Scholar 

  46. Patronas NJ, Di Chiro G, Kufta C et al (1985) Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62: 816–822

    Google Scholar 

  47. Kornblith PL, Cummins CJ, Smith BH, Brooks RA, Patronas NJ, Di Chiro G (1984) Correlation of experimental and clinical studies of metabolism by PET scanning. Prog Exp Tumour Res 27: 170–178

    Google Scholar 

  48. Graham JF, Cummins CJ, Smith BH, Kornblith PL (1985) Regulation of hexokinase in cultured gliomas. Neurosurgery 17: 537–542

    Google Scholar 

  49. Alger JR, Frank JA, Bizzi A, et al (1990) Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 177: 633–641

    Google Scholar 

  50. Brooks JD, Beaney RP, Thomas DGT, Marshall J, Jones T (1986) Studies in regional cerebral pH in patients with cerebral tumours using continuous inhalation of11CO2 and positron emission tomography. J Cerebr Blood Flow Metab 6: 529–535

    Google Scholar 

  51. Buxton RB, Wechsler LR, Alpert NM, Ackerman RH, Elmaleh DR, Correia JA (1984) Measurement of brain pH using11CO2 and positron emission tomography. J Cerebr Blood Flow Metab 4: 8–16

    Google Scholar 

  52. Hochachka PW, Mommsen TP (1983) Protons and anaerobiosis. Science 219: 1391–1397

    Google Scholar 

  53. Heesters MAAM, Kamman RL, Mooyaart EL, Go KG (1993) Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy. J Neuro-Oncol 17: 27–35

    Google Scholar 

  54. Ott D, Hennig J, Ernst T (1993) Human brain tumours: assessment with in vivo proton MR spectroscopy. Radiology 186: 745–752

    Google Scholar 

  55. Kayama T, Yoshimoto T, Fujimoto S, Sakurai Y (1991) Intratumoural oxygen pressure in malignant brain tumour. J Neurosurg 74: 55–59

    Google Scholar 

  56. Cruickshank GS, Rampling R (1994) Peritumoural hypoxia in human brain: peroperative measurement of the tissue oxygen tension around malignant brain tumours. Acta Neurochir [Suppl] 60: 375–380

    Google Scholar 

  57. Maier-Hauff K, Gerlach L, Cordes M (1990) HM-PAO-SPECT in the differentiation of cerebral gliomas. First experiences with blood flow measurements. In: Schneider GH, Vogler E, Kocever K (eds) Digitale Bildgebung, interventionelle Radiologie, integrierte digitale Radiologie. Blackwell, Oxford, pp 40–46

    Google Scholar 

  58. Go KG, Hew JW, Kamman RL, Molenaar WM, Pruim J, Blaauw EH (1993) Cystic lesions of the brain. A classification based on pathogenesis, with consideration of histological and radiological features. Eur J Radiol 17: 69–84

    Google Scholar 

  59. Van Vaals JJ, Bergman AH, Van den Boogert HJ, et al (1991) Non-invasive in vivo localised1H spectroscopy of human astrocytoma implanted in rat brain: regional differences followed in time. NMR Biomed 4: 125–132

    Google Scholar 

  60. Go KG, Keuter E, Kamman RL, Pruim J, Metzemaekers JDM, Staal MJ, Paans AMJ, Vaalburg W (1994) Contribution of magnetic resonance spectroscopic imaging and L-[11C]-tyrosine positron emission tomography to localization of cerebral gliomas for biopsy. Neurosurgery 34: 994–1002

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Go, K.G., Kamman, R.L., Mooyaart, E.L. et al. Localised proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography. Neuroradiology 37, 198–206 (1995). https://doi.org/10.1007/BF01578258

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01578258

Key words

Navigation